Table 3.
Authors | Study Population | Intervention | Results |
---|---|---|---|
Hepler et al., 1971 [4] | 11 healthy subjects | 18 mg delta-9-THC | 24% IOP lowering (limited data available) |
Flom et al., 1975 [20] | 15 healthy subjects | 12 mg delta-9-THC | 13% IOP lowering after 80 min from administration |
Hepler et al., 1976 [56] | 136 subjects affected by POAG administered with 1, 2, or 4% THC cigarette | 20 mg delta-9-THC (2 g marijuana cigarette with 1% delta-9-THC) |
29% and 22% IOP lowering after 30 and 180 min from administration |
40 mg delta-9-THC (2 g marijuana cigarette with 2% delta-9-THC) |
25% and 17% IOP lowering after 30 and 180 min from administration | ||
80 mg delta-9-THC (2 g marijuana cigarette with 4% delta-9-THC) |
34% and 22% IOP lowering after 30 and 180 min from administration | ||
Hepler et al., 1976 [57] | 40 healthy subjects | 1% natural delta-9-THC cigarette | 30% IOP lowering 30 min after administration |
2% natural delta-9-THC cigarette | 25% IOP lowering 30 min after administration | ||
4% natural delta-9-THC cigarette | 34% IOP lowering min after administration | ||
1% synthetic delta-9-THC cigarette | 15% IOP lowering 30 min after administration | ||
2% synthetic delta-9-THC cigarette | 23% IOP lowering 30 min after administration | ||
4% synthetic delta-9-THC cigarette | 24% IOP lowering 30 min after administration | ||
Merritt et al., 1980 [65] | 18 glaucoma patients (12 affected by POAG, 6 affected by secondary glaucoma) | 18 mg delta-9-THC (0.9 g marijuana cigarette with 2% delta-9-THC) |
14.5% and 23.4% IOP lowering after 30 and 90 min from administration |
(POAG: primary open angle glaucoma, IOP intraocular pressure, THC Tetrahydrocannabinol.).